Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Pharmadesign, Inc.”

5 pharma patents match "Pharmadesign, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "Pharmadesign, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “Pharmadesign, Inc.” · 30,257 patents in full index Clear search

  1. US 9018238

    Inhibitor of casein kinase 1δ and casein kinase 1ε

    Pharmadesign, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  2. US 8796320

    1,3,4-Oxadiazole-2-carboxamide compound

    Pharmadesign, Inc. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  3. US 8710231

    Inhibitor of casein kinase 1delta and casein kinase 1E

    Pharmadesign, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  4. US 8466290

    STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient

    Pharmadesign, Inc. · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  5. US 7396816

    Low-molecular weight peptides inhibiting ion channel activity

    Pharmadesign, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.